Name | 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole |
---|---|
Synonyms |
Omeprazole sulfide
5-METHOXY-2-[((4-METHOXY-3,5 Ufiprazol 5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl thio-1H-benzimidazole; (Intermediate of Omeprazole) Pyrmetazole 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]thio]-1H-benzimidazole EINECS 208-591-9 MFCD00869021 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl]thio]benzimidazole omeprazole sulphide 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylthio]-1H-benzimidazole 5-METHOXY-2-((3,5-DIMETHYL-4-METHOXY-2-PYRIDINYL)-METHYLTHIO)-1H-BENZIMIDAZOLE ufiprazole Ufiprazolum 5-Methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole 2-{[(3,5-dimethyl-4-methoxy-2-pyridinyl)-methyl]-thio}-5-methoxy-1h-benzimidazole 6-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)methyl]sulfanyl}-1h-Benzimidazole 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]- 5-Methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole Esomeprazole Impurity 3 Omeprazole metabolite Omeprazole sulfide |
Description | Omeprazole sulfide is a metabolite of Omeprazole, which is a proton pump inhibitor. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 539.7±60.0 °C at 760 mmHg |
Melting Point | 124 °C |
Molecular Formula | C17H19N3O2S |
Molecular Weight | 329.417 |
Flash Point | 280.2±32.9 °C |
Exact Mass | 329.119812 |
PSA | 85.33000 |
LogP | 3.87 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.649 |
Storage condition | -20°C Freezer |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36/37/38 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
HS Code | 2933990090 |
~84% 73590-85-9 |
Literature: Kuraray Co., Ltd. Patent: US6197962 B1, 2001 ; |
~91% 73590-85-9 |
Literature: ORCHID CHEMICALS and PHARMACEUTICALS LTD; REGURI, Buchi Reddy; UPPARAPALLI, Sampathkumar; SIVADAS, Anand; VIGNESWARA CHELLAM, Ravisankar; SHANMUGA SUNDARAM, Bharani Kumar; SUBBAIAH, Ramesh Patent: WO2011/12957 A1, 2011 ; Location in patent: Page/Page column 16 ; |
~% 73590-85-9 |
Literature: US2007/82929 A1, ; Page/Page column 42 ; US 20070082929 A1 |
~% 73590-85-9 |
Literature: WO2004/35565 A1, ; Page 5; 8-9 ; |
~77% 73590-85-9 |
Literature: Cipla Limited Patent: EP1085019 A1, 2001 ; |
~93% 73590-85-9 |
Literature: Kuraray Co., Ltd. Patent: US6350876 B2, 2002 ; Location in patent: Example 23 ; |
~87% 73590-85-9 |
Literature: Kuraray Co., Ltd. Patent: US6350876 B2, 2002 ; Location in patent: Example 22 ; |
~% 73590-85-9 |
Literature: Synthetic Communications, , vol. 32, # 8 p. 1211 - 1217 |
~% 73590-85-9 |
Literature: Rane; Pathak; Kaushik; Prasad Rao; Kumar, Ashok Synthetic Communications, 2002 , vol. 32, # 8 p. 1211 - 1217 |
Precursor 10 | |
---|---|
DownStream 4 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |